Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,021,000 | 8,510,000 | 6,327,000 | 3,275,000 | 1,315,000 |
| Depreciation Amortization | 689,000 | 2,760,000 | 2,073,000 | 1,387,000 | 696,000 |
| Income taxes - deferred | 179,000 | 160,000 | 282,000 | -377,000 | -199,000 |
| Accounts receivable | 134,000 | -367,000 | -546,000 | -213,000 | 79,000 |
| Accounts payable and accrued liabilities | -67,000 | -132,000 | -37,000 | -267,000 | -105,000 |
| Other Working Capital | -604,000 | -2,924,000 | -2,859,000 | -2,732,000 | -780,000 |
| Other Operating Activity | 192,000 | 2,012,000 | 1,452,000 | 1,511,000 | 751,000 |
| Operating Cash Flow | $2,544,000 | $10,019,000 | $6,692,000 | $2,584,000 | $1,757,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,031,000 | -3,030,000 | -2,011,000 | -1,977,000 | 0 |
| PPE Investments | -117,000 | -563,000 | -358,000 | -211,000 | -104,000 |
| Net Acquisitions | -109,000 | -1,070,000 | -461,000 | -294,000 | -273,000 |
| Purchase Of Investment | -19,000 | -133,000 | -119,000 | -37,000 | -16,000 |
| Other Investing Activity | -16,000 | 3,000 | -9,000 | -12,000 | -22,000 |
| Investing Cash Flow | $1,770,000 | $-4,793,000 | $-2,958,000 | $-2,531,000 | $-415,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,766,000 | -1,788,000 | -1,780,000 | -1,771,000 | -1,762,000 |
| Common Stock Issued | 166,000 | 408,000 | 376,000 | 279,000 | 252,000 |
| Common Stock Repurchased | -419,000 | -1,922,000 | -1,692,000 | -1,257,000 | -730,000 |
| Dividend Paid | -1,040,000 | -4,003,000 | -3,009,000 | -2,004,000 | -1,010,000 |
| Other Financing Activity | -180,000 | -440,000 | -377,000 | -240,000 | -176,000 |
| Financing Cash Flow | $-4,239,000 | $-7,745,000 | $-6,482,000 | $-4,993,000 | $-3,426,000 |
| Exchange Rate Effect | -11,000 | 92,000 | 87,000 | 92,000 | 19,000 |
| Beginning Cash Position | 7,564,000 | 9,991,000 | 9,991,000 | 9,991,000 | 9,991,000 |
| End Cash Position | 7,628,000 | 7,564,000 | 7,330,000 | 5,144,000 | 7,926,000 |
| Net Cash Flow | $65,000 | $-2,428,000 | $-2,661,000 | $-4,848,000 | $-2,065,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,544,000 | 10,019,000 | 6,692,000 | 2,584,000 | 1,757,000 |
| Capital Expenditure | -117,000 | -563,000 | -358,000 | -211,000 | -104,000 |
| Free Cash Flow | 2,427,000 | 9,456,000 | 6,334,000 | 2,373,000 | 1,653,000 |